Brought to you by 
Hoechst will acquire Syva from Roche for $204-408 million
Mar 1995
Executive Summary
Hoechst acquired Roche division Syva for one to two times Syva's annual revenues ($204-408 million) and merged its operations with its diagnostics subsidiary Behring Diagnostics.
Deal Industry
- In Vitro Diagnostics
-
In Vitro Diagnostics
- Chemistry, Immunoassay
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
Advertisement
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Hoechst will acquire Syva from Roche for $204-408 million
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice